Sanofi Receives Indian Approval for Qfitlia, a New RNA-Based Treatment for Haemophilia A and B

An important feature of the approval is that the treatment covers patients both with and without inhibitors against clotting factors VIII or IX. This distinction is particularly significant because the development of inhibitors can complicate conventional haemophilia treatment.
Read the full report on Dharmakshethra - India Unabridged
Story file
- Section
- Health
- First reported by
- Dharmakshethra - India Unabridged
- Reporter
- kautilya
- Published
- Thursday, 22 October 2026, 10:15 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Dharmakshethra - India Unabridged with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

